查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947915

核酸增幅检查市场分析及预测（至2035年）：依类型、产品类型、技术、应用、最终用户、组件、製程、设备及模式划分

Nucleic Acid Amplification Testing Market Analysis and Forecast to 2035: Type, Product, Technology, Application, End User, Component, Process, Equipment, Mode
出版日期: | 出版商: Global Insight Services | 英文 301 Pages | 商品交期: 3-5个工作天内

价格
简介目录

核酸增幅检查市场预计将从2024年的106亿美元成长到2034年的366亿美元，复合年增长率约为14.5%。核酸增幅检查市场涵盖了扩增核酸以检测病原体、基因突变或生物标记的诊断技术。这些方法，包括PCR和等温扩增，在感染疾病诊断、肿瘤学和个人化医疗中至关重要。对快速准确诊断日益增长的需求，以及技术的进步，正在推动市场成长，其中自动化、高灵敏度和照护现场解决方案尤其重要。

核酸增幅检查(NAAT) 市场正经历强劲成长，这主要得益于分子诊断技术的进步以及对精准病原体检测需求的不断增长。聚合酵素链锁反应(PCR) 是成长最快的细分市场，因其准确性和在临床诊断中的广泛应用而备受认可。即时PCR作为 PCR 的一个子集，因其快速通量和定量分析能力而特别突出。转录媒介增幅(TMA) 是第二大成长最快的细分市场，这主要归功于其在感染疾病检测方面卓越的灵敏度和速度。在终端用户领域，医院和诊断检查室主导NAAT 的发展，这主要得益于 NAAT 在疾病早期检测和管理方面的应用日益广泛。研究机构和学术中心是第二大盈利最快的细分市场，它们利用这些技术进行创新研发。对个人化医疗的日益重视以及对快速可靠诊断解决方案的需求正在推动 NAAT 市场的发展，并为相关人员提供了盈利的机会。

市场区隔
类型 聚合酵素链锁反应（PCR）、等温扩增、连接酶炼式反应（LCR）、转录媒介增幅（TMA）、链置换扩增（SDA）、解旋酶依赖性扩增（HDA）、恒温环型核酸扩增（LA）
产品 设备、试剂和耗材、软体和服务
科技 即时PCR、数位PCR、多重PCR
应用领域 感染疾病、癌症、基因检测、刑事鑑定、血液筛检
最终用户 医院和诊断检查室、研究机构、生物技术和製药公司、受託研究机构
成分 试剂盒及检测方法、分析设备
过程 样品製备、扩增及检测
装置 聚合酵素连锁反应热迴圈仪，自动核酸萃取装置
模式 临床试验、研究性试验

核酸增幅检查(NAAT) 市场的特点是市场份额分布动态变化、定价策略复杂以及创新产品层出不穷。 NAAT 以其准确性和快速检测结果而闻名，在各个细分市场中展现出强劲的需求。各公司正透过具竞争力的价格和尖端产品的推出，进行策略性布局以抢占市场份额。持续的技术进步进一步加剧了这种竞争环境，提升了产品的差异化和市场吸引力。 NAAT 市场由少数主要企业主导，这些企业利用技术创新来保持其竞争优势。基准研究表明，这些公司正致力于拓展产品系列併提高营运效率。监管因素，特别是北美和欧洲的严格指导方针，透过设定高标准的产品品质和安全要求，正在塑造市场动态。这些法规在带来挑战的同时，也为企业提供了创新和产品差异化的机会，进而影响市场成长和普及。

主要趋势和驱动因素：

核酸增幅检查(NAAT) 市场正经历强劲成长，这主要得益于分子诊断技术的进步以及对快速、准确检测解决方案日益增长的需求。一个关键趋势是将 NAAT 与就地检验设备结合，从而实现疾病的快速诊断和管理。这一趋势在感染疾病防治领域尤其明显，因为及时干预至关重要。此外，个人化医疗的兴起也推动了市场发展。 NAAT 越来越多地应用于基因检测，有助于制定个人化治疗方案，从而改善患者预后。市场也受惠于技术创新，例如等温扩增技术的开发，该技术能够提供更快、更经济高效的检测结果。此外，COVID-19 疫情凸显了完善的侦测基础设施的重要性，加速了 NAAT 在全球医疗系统中的应用。新兴市场蕴藏着许多机会，这些市场的医疗基础设施正在不断完善，人们对疾病的早期检测和预防也越来越感兴趣。能够提供扩充性、高效且经济实惠的检测解决方案的公司有望占据显着的市场份额。对改善医疗服务和治疗效果的关注将继续推动对 NAAT 技术的需求。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 聚合酵素链锁反应（PCR）
    • 等温扩增
    • 连接酶炼式反应（LCR）
    • 转录媒介增幅（TMA）
    • 链置换扩增（SDA）
    • 解旋酶依赖性扩增（HDA）
    • 恒温环型核酸扩增（LAMP）
  • 市场规模及预测：依产品划分
    • 装置
    • 试剂和耗材
    • 软体和服务
  • 市场规模及预测：依技术划分
    • 即时PCR
    • 数位PCR
    • 多重PCR
  • 市场规模及预测：依应用领域划分
    • 感染疾病
    • 癌症
    • 基因检测
    • 法医检验
    • 血液筛检
  • 市场规模及预测：依最终用户划分
    • 医院和诊断检查室
    • 研究所
    • 生物技术和製药公司
    • 合约研究机构
  • 市场规模及预测：依组件划分
    • 试剂盒和检测
    • 分析器
  • 市场规模及预测：依製程划分
    • 样品製备
    • 放大
    • 侦测
  • 市场规模及预测：依设备划分
    • 聚合酵素连锁反应热迴圈仪
    • 自动核酸萃取装置
  • 市场规模及预测：依方法
    • 实验室测试
    • 研究与测试

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Bio-Rad Laboratories
  • Luminex Corporation
  • Cepheid
  • Dia Sorin
  • QIAGEN
  • Hologic
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Abbott Laboratories
  • bio Merieux
  • Agilent Technologies
  • Illumina
  • Perkin Elmer
  • Tecan Group
  • Promega Corporation
  • Gen Mark Diagnostics
  • Quidel Corporation
  • Meridian Bioscience
  • Fluidigm Corporation
  • Bio Fire Diagnostics

第九章：关于我们

简介目录
Product Code: GIS10512

Nucleic Acid Amplification Testing Market is anticipated to expand from $10.6 billion in 2024 to $36.6 billion by 2034, growing at a CAGR of approximately 14.5%. The Nucleic Acid Amplification Testing Market encompasses diagnostic techniques that amplify nucleic acids to detect pathogens, genetic mutations, or biomarkers. These methods, including PCR and isothermal amplification, are pivotal in infectious disease diagnosis, oncology, and personalized medicine. Rising demand for rapid and accurate diagnostics, coupled with technological advancements, propels market growth, emphasizing automation, sensitivity, and point-of-care solutions.

The Nucleic Acid Amplification Testing (NAAT) Market is experiencing robust growth, fueled by advancements in molecular diagnostics and heightened demand for precise pathogen detection. The polymerase chain reaction (PCR) segment is the top-performing sub-segment, revered for its accuracy and widespread application in clinical diagnostics. Real-time PCR, a subset, is particularly prominent due to its rapid processing capabilities and quantitative analysis. The transcription-mediated amplification (TMA) segment follows as the second highest-performing, offering advantages in sensitivity and speed for detecting infectious diseases. In the end-user landscape, the hospital and diagnostic laboratories segment leads, driven by the increasing adoption of NAAT for early disease detection and management. Research institutes and academic centers are the second most lucrative, as they leverage these technologies for innovative research and development. The growing emphasis on personalized medicine and the need for rapid, reliable diagnostic solutions propel the NAAT market forward, offering lucrative opportunities for stakeholders.

Market Segmentation
TypePolymerase Chain Reaction (PCR), Isothermal Amplification, Ligase Chain Reaction (LCR), Transcription Mediated Amplification (TMA), Strand Displacement Amplification (SDA), Helicase-Dependent Amplification (HDA), Loop-Mediated Isothermal Amplification (LA)
ProductInstruments, Reagents and Consumables, Software and Services
TechnologyReal-Time PCR, Digital PCR, Multiplex PCR
ApplicationInfectious Diseases, Cancer, Genetic Testing, Forensic Testing, Blood Screening
End UserHospitals and Diagnostic Laboratories, Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations
ComponentKits and Assays, Analyzers
ProcessSample Preparation, Amplification, Detection
EquipmentThermal Cyclers, Automated Nucleic Acid Extractors
ModeClinical Testing, Research Testing

The Nucleic Acid Amplification Testing (NAAT) market is characterized by a dynamic landscape of market share distribution, pricing strategies, and innovative product launches. Renowned for its precision and rapid results, the NAAT market is witnessing robust demand across various sectors. Companies are strategically positioning themselves through competitive pricing and the introduction of cutting-edge products to capture market share. This competitive environment is further intensified by the continuous advancement in technology, which drives product differentiation and enhances market appeal. In terms of competition, the NAAT market is dominated by a few key players who are leveraging technological advancements to maintain their competitive edge. Benchmarking reveals that these players are focusing on expanding their product portfolios and enhancing operational efficiency. Regulatory influences, particularly stringent guidelines in North America and Europe, are shaping market dynamics by setting high standards for product quality and safety. These regulations, while challenging, also present opportunities for companies to innovate and differentiate their offerings, thereby influencing market growth and adoption.

Geographical Overview:

The Nucleic Acid Amplification Testing (NAAT) market is witnessing notable growth across various regions, each presenting unique opportunities. North America remains a dominant player, driven by advanced healthcare infrastructure and increasing demand for accurate diagnostic tools. The region's focus on precision medicine further propels market expansion. Europe follows closely, with strong investments in biotechnology and a robust regulatory framework supporting NAAT adoption. Asia Pacific is emerging as a significant growth pocket, fueled by rising healthcare expenditures and technological advancements. Countries like China and India are at the forefront, investing heavily in diagnostic technologies to enhance healthcare outcomes. Latin America and the Middle East & Africa are also gaining traction, with increasing awareness and adoption of NAAT for infectious disease management. Brazil and South Africa are notable emerging markets, recognizing the importance of advanced diagnostic solutions in improving public health and driving economic growth.

The global tariff landscape and geopolitical tensions are significantly influencing the Nucleic Acid Amplification Testing Market. Japan and South Korea are navigating US-China trade tensions by bolstering domestic production capabilities and investing in biotechnological innovation. China's strategy focuses on reducing dependency on foreign technologies, fostering home-grown advancements in nucleic acid testing technologies. Taiwan, a pivotal player in semiconductor supply chains, faces geopolitical risks but remains integral to the market's growth. The parent market is experiencing robust global demand driven by increased healthcare awareness and infectious disease control. By 2035, market evolution will hinge on supply chain resilience and technological self-reliance. Middle East conflicts could exacerbate global supply chain disruptions and elevate energy prices, indirectly affecting production costs and market dynamics.

Key Trends and Drivers:

The Nucleic Acid Amplification Testing (NAAT) market is experiencing robust growth driven by advancements in molecular diagnostics and increased demand for rapid and accurate testing solutions. A key trend is the integration of NAAT with point-of-care testing devices, allowing for swift disease diagnosis and management. This trend is particularly pronounced in infectious disease control, where timely intervention is critical. Moreover, the rise of personalized medicine is propelling the market forward. NAAT is increasingly utilized in genetic testing, enabling tailored treatment plans that improve patient outcomes. The market is also benefiting from technological innovations, such as the development of isothermal amplification techniques that offer faster results and are more cost-effective. Additionally, the COVID-19 pandemic has underscored the importance of robust testing infrastructure, accelerating the adoption of NAAT across healthcare systems globally. Opportunities abound in emerging markets where healthcare infrastructure is expanding, and there is a growing emphasis on early disease detection and prevention. Companies that can offer scalable, efficient, and affordable testing solutions are poised to capture significant market share. The focus on improving healthcare access and outcomes will continue to drive demand for NAAT technologies.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Application
  • 2.5 Key Market Highlights by End User
  • 2.6 Key Market Highlights by Component
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Equipment
  • 2.9 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Polymerase Chain Reaction (PCR)
    • 4.1.2 Isothermal Amplification
    • 4.1.3 Ligase Chain Reaction (LCR)
    • 4.1.4 Transcription Mediated Amplification (TMA)
    • 4.1.5 Strand Displacement Amplification (SDA)
    • 4.1.6 Helicase-Dependent Amplification (HDA)
    • 4.1.7 Loop-Mediated Isothermal Amplification (LAMP)
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Reagents and Consumables
    • 4.2.3 Software and Services
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Real-Time PCR
    • 4.3.2 Digital PCR
    • 4.3.3 Multiplex PCR
  • 4.4 Market Size & Forecast by Application (2020-2035)
    • 4.4.1 Infectious Diseases
    • 4.4.2 Cancer
    • 4.4.3 Genetic Testing
    • 4.4.4 Forensic Testing
    • 4.4.5 Blood Screening
  • 4.5 Market Size & Forecast by End User (2020-2035)
    • 4.5.1 Hospitals and Diagnostic Laboratories
    • 4.5.2 Research Institutes
    • 4.5.3 Biotechnology and Pharmaceutical Companies
    • 4.5.4 Contract Research Organizations
  • 4.6 Market Size & Forecast by Component (2020-2035)
    • 4.6.1 Kits and Assays
    • 4.6.2 Analyzers
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Sample Preparation
    • 4.7.2 Amplification
    • 4.7.3 Detection
  • 4.8 Market Size & Forecast by Equipment (2020-2035)
    • 4.8.1 Thermal Cyclers
    • 4.8.2 Automated Nucleic Acid Extractors
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 Clinical Testing
    • 4.9.2 Research Testing

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Application
      • 5.2.1.5 End User
      • 5.2.1.6 Component
      • 5.2.1.7 Process
      • 5.2.1.8 Equipment
      • 5.2.1.9 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Application
      • 5.2.2.5 End User
      • 5.2.2.6 Component
      • 5.2.2.7 Process
      • 5.2.2.8 Equipment
      • 5.2.2.9 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Application
      • 5.2.3.5 End User
      • 5.2.3.6 Component
      • 5.2.3.7 Process
      • 5.2.3.8 Equipment
      • 5.2.3.9 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Application
      • 5.3.1.5 End User
      • 5.3.1.6 Component
      • 5.3.1.7 Process
      • 5.3.1.8 Equipment
      • 5.3.1.9 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Application
      • 5.3.2.5 End User
      • 5.3.2.6 Component
      • 5.3.2.7 Process
      • 5.3.2.8 Equipment
      • 5.3.2.9 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Application
      • 5.3.3.5 End User
      • 5.3.3.6 Component
      • 5.3.3.7 Process
      • 5.3.3.8 Equipment
      • 5.3.3.9 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Application
      • 5.4.1.5 End User
      • 5.4.1.6 Component
      • 5.4.1.7 Process
      • 5.4.1.8 Equipment
      • 5.4.1.9 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Application
      • 5.4.2.5 End User
      • 5.4.2.6 Component
      • 5.4.2.7 Process
      • 5.4.2.8 Equipment
      • 5.4.2.9 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Application
      • 5.4.3.5 End User
      • 5.4.3.6 Component
      • 5.4.3.7 Process
      • 5.4.3.8 Equipment
      • 5.4.3.9 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Application
      • 5.4.4.5 End User
      • 5.4.4.6 Component
      • 5.4.4.7 Process
      • 5.4.4.8 Equipment
      • 5.4.4.9 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Application
      • 5.4.5.5 End User
      • 5.4.5.6 Component
      • 5.4.5.7 Process
      • 5.4.5.8 Equipment
      • 5.4.5.9 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Application
      • 5.4.6.5 End User
      • 5.4.6.6 Component
      • 5.4.6.7 Process
      • 5.4.6.8 Equipment
      • 5.4.6.9 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Application
      • 5.4.7.5 End User
      • 5.4.7.6 Component
      • 5.4.7.7 Process
      • 5.4.7.8 Equipment
      • 5.4.7.9 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Application
      • 5.5.1.5 End User
      • 5.5.1.6 Component
      • 5.5.1.7 Process
      • 5.5.1.8 Equipment
      • 5.5.1.9 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Application
      • 5.5.2.5 End User
      • 5.5.2.6 Component
      • 5.5.2.7 Process
      • 5.5.2.8 Equipment
      • 5.5.2.9 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Application
      • 5.5.3.5 End User
      • 5.5.3.6 Component
      • 5.5.3.7 Process
      • 5.5.3.8 Equipment
      • 5.5.3.9 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Application
      • 5.5.4.5 End User
      • 5.5.4.6 Component
      • 5.5.4.7 Process
      • 5.5.4.8 Equipment
      • 5.5.4.9 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Application
      • 5.5.5.5 End User
      • 5.5.5.6 Component
      • 5.5.5.7 Process
      • 5.5.5.8 Equipment
      • 5.5.5.9 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Application
      • 5.5.6.5 End User
      • 5.5.6.6 Component
      • 5.5.6.7 Process
      • 5.5.6.8 Equipment
      • 5.5.6.9 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Application
      • 5.6.1.5 End User
      • 5.6.1.6 Component
      • 5.6.1.7 Process
      • 5.6.1.8 Equipment
      • 5.6.1.9 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Application
      • 5.6.2.5 End User
      • 5.6.2.6 Component
      • 5.6.2.7 Process
      • 5.6.2.8 Equipment
      • 5.6.2.9 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Application
      • 5.6.3.5 End User
      • 5.6.3.6 Component
      • 5.6.3.7 Process
      • 5.6.3.8 Equipment
      • 5.6.3.9 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Application
      • 5.6.4.5 End User
      • 5.6.4.6 Component
      • 5.6.4.7 Process
      • 5.6.4.8 Equipment
      • 5.6.4.9 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Application
      • 5.6.5.5 End User
      • 5.6.5.6 Component
      • 5.6.5.7 Process
      • 5.6.5.8 Equipment
      • 5.6.5.9 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Bio- Rad Laboratories
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Luminex Corporation
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Cepheid
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Dia Sorin
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 QIAGEN
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Hologic
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Thermo Fisher Scientific
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Roche Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Abbott Laboratories
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 bio Merieux
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Agilent Technologies
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Illumina
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Perkin Elmer
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Tecan Group
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Promega Corporation
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Gen Mark Diagnostics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Quidel Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Meridian Bioscience
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Fluidigm Corporation
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Bio Fire Diagnostics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us